Inventor · disambiguated record
Harshil Dhruv
Also filed as: DHRUV HARSHIL · DHRUV HARSHIL DINESHKUMAR
8 granted patents·1 pending application·32 citations·filing 2009–2021
82Inventor score
Files withTRANSLATIONAL GENOMICS RES INST4DIGNITY HEALTH2SUMITOMO PHARMA ONCOLOGY INC1THE TRANSLATIONAL GENOMICS RES INST1UNIV UTAH STATE1
Top patents by PatentIndex Score
9 records- 0189US9238034B2FN14 antagonists and therapeutic uses thereofTRANSLATIONAL GENOMICS RES INST·Filed 2014·Granted Jan 19, 2016·12 cites·9 claims
- 0288US9797882B2Method of screening for a compound for inhibitory activity of FN14-tweak interactionTHE TRANSLATIONAL GENOMICS RES INST·Filed 2014·Granted Oct 24, 2017·11 cites·11 claims
- 0381US8053548B2Hydrophilic surface modification of polydimethylsiloxaneUNIV UTAH STATE·Filed 2009·Granted Nov 8, 2011·6 cites·2 claims
- 0474US9872857B2Methods of using propentofylline to treat glioma and glioblastomaTRANSLATIONAL GENOMICS RES INST·Filed 2016·Granted Jan 23, 2018·1 cites·16 claims
- 0573US9637798B2Genetic signature of vulnerability to inhibitors of base excision repair (BER) in cancerDIGNITY HEALTH·Filed 2014·Granted May 2, 2017·2 cites·10 claims
- 0663US10426777B2Methods used to treat cancerTRANSLATIONAL GENOMICS RES INST·Filed 2017·Granted Oct 1, 2019·0 cites·14 claims
- 0757US10227659B2Genetic signature of vulnerability to inhibitors of base excision repair (BER) in cancerDIGNITY HEALTH·Filed 2017·Granted Mar 12, 2019·0 cites·3 claims
- 0853US2023090742A1Aminopyrimidinylaminobenzonitrile derivatives as nek2 inhibitorsSUMITOMO PHARMA ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 0952US10624895B2Methods of sensitizing a patient with glioma to a therapeutic agent by administering small hairpin RNA targeting PDZ-RHOGEFTRANSLATIONAL GENOMICS RES INST·Filed 2016·Granted Apr 21, 2020·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →